Journal article icon

Journal article

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.

Abstract:

OBJECT: Pexelizumab is a humanized monoclonal antibody inhibiting C5 complement. It has been postulated to improve outcomes in patients undergoing coronary artery bypass surgery and urgent reperfusion therapy for ST elevation myocardial infarction. We aimed at evaluating the risk/benefit profile of pexelizumab (bolus + infusion) versus placebo on top of current approaches in the management of patients with ST elevation myocardial infarction or undergoing coronary artery bypass. METHODS: We c...

Expand abstract

Actions


Access Document


Publisher copy:
10.1016/j.jtcvs.2007.12.062

Authors


Journal:
Journal of thoracic and cardiovascular surgery More from this journal
Volume:
136
Issue:
4
Pages:
884-893
Publication date:
2008-10-01
DOI:
EISSN:
1097-685X
ISSN:
0022-5223

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP